Previous studies of our research group found that antitussive agent cloperastine and 5-hydroxytryptamine 4-receptor partial agonist tegaserod maleate have a good inhibitory effect on the proliferation of ESCC and can effectively prevent the recurrence of ESCC [33, 34]. This evidence concerns the gene HTR4 and esophageal squamous cell carcinoma.